Protects against
radiation injuries
Prevent occupational diseases (cancer, cataract, cognitive disorders, DNA damage and other X-ray-exposure related conditions).
Discover Nova-X®: the only full-body, team-wide protection system providing an unmatched radiation protection level thanks to unique proprietary materials and technologies. * Based on NOVARAD1 preliminary clinical results presented at LINNC2025
NOVARAD is the world-first multicentric comparative study to evaluate lead-free procedures
NOVARAD is the world-first multicentric comparative study to evaluate lead-free procedures
Prevent occupational diseases (cancer, cataract, cognitive disorders, DNA damage and other X-ray-exposure related conditions).
66% of interventionalists suffer from MSDs.
Transition toward lead-free procedures.
Encourages interventionalists to perform more complex, distal and longer procedures for the patient’s benefit.
Reduces sick leave due to occupational hazards.
Decreases stress and fatigue among cath-lab staff.
Promotes engagement of women in interventional careers.
Head of Interventional Cardiology Unit
The Nova-X is an essential piece of equipment for the Cathlab. The cabin provides optimum protection against X-rays and prevents muscular problems for the operator, since the Nova-X cabin makes it possible to remove the lead apron. I recommend using the cabin for all interventional cardiology procedures.
Director of the Cardiology Department
The system is really easy to use and can be used for both simple and complex procedures (e.g. CTO). I recommend using the Nova-X for complex and lengthy procedures, as it offers the operator optimum protection and eliminates the need to wear protective clothing.
Interventional Neuroradiologist
I would say that Nova-X helped me to come back to work in good conditions, drastically reducing back pain. I discovered a new way of working which brings a lot of benefits beyond the comfort of no wearing lead apron.
Experience unmatched radiation protection with unique patented materials offering 2 mm lead equivalency.
These ceiling-mounted glass panels made from patented lead-free Novashield glass® protect against scattered radiation from the ceiling, which is often underestimated in the cathlab
This yellowing and stress-resistant material offers perfect patient vision thanks to its high transparency and provides a 2 mm lead equivalence optimally protecting the entire team.
These flexible lead-free shutters ensure optimal radiation protection against scattered radiation from the patient. Thanks to their flexibility, the shutters can be adjusted for each patient’s profile
The system provides real-time dose rate reduction (Dosicath®) and a controlled radiation protection zone figured on the floor with lasers (Laserguard®)
This proprietary technology displays real-time dose rate reduction inside and outside of the system. It allows for immediate corrective actions in case of dose leakage caused by incorrect system positioning. All doses can also be recorded and stored on a dedicated platform for each procedure
This proprietary technology, specifically designed for Nova-X®, delineates a zone on the floor where radiation protection is effective for Healthcare providers. Nova-X® is the only full-body radiation protection system offering this key safety feature.
Nova-X offers outstanding ergonomics to limit its footprint and ensure perfect fit with any cathlab
Thanks its flexible frame and specially designed front wheels, Nova-X® is compatible with bi-plane c-arms (all incidences) and with any imaging system.
This proprietary technology ensures effortless mobility (4kg) for all users, allowing smooth and precise movement at a controlled speed, with minimal bulk thanks to a triple rotation axis system. This system also ensures effortless small movements during the procedure
Founded in 2024, Cathpax designs, develops and commercialises innovative, full-body, team-wide radiation protection systems for cath lab staff during interventional procedures. As part of the Lemer Pax group, the company leverages more than 50 years of innovation in the radiation protection field. A pioneer in ionising radiation protection since the 1970s, Lemer Pax spent the past two decades developing groundbreaking innovations
to advance its mission of Protecting Life® over the last two decades. The group has created cutting-edge radiation protection materials and technologies used in thousands of products worldwide. Today, Lemer Pax covers three major areas of expertise through three different entities: Lemer Pax (Civilian nuclear sector, radiopharmacy, nuclear medicine and radiology), GMP (therapy radioisotope production) and Cathpax (interventional medicine).
Developed over more than ten years of R&D, Nova-X® is Cathpax’s second-generation radiation-protection system. Protected by 16 patents, Nova-X® is currently the only available solution on the market providing 2 mm lead equivalence. The system features a unique dose-monitoring module that displays real-time dose attenuation (Dosicath®) and a built-in laser that projects two green beams onto the floor, clearly marking a safety zone to ensure full protection of healthcare providers (LaserGuard®). Developed over more than 10 years of research & development, Nova-X® is Cathpax’s second-generation radiation protection system. Protected by 16 patents, Nova-X® is currently the only available solution on the market providing 2 mm lead equivalence. The system features a unique dose monitoring system displaying real-time dose rate reduction (Dosicath®). Nova-X® also boasts a built-in laser system that projects two green laser beams onto the floor, clearly marking out a controlled zone for Healthcare providers (Laserguard®). Thanks to all these unique features, Nova-X® drastically improves cath lab staff safety and comfort, promoting stress-free working conditions through efficient full body and team-wide protection against radiation injuries, ultimately benefiting the patient.
Nova-X® received CE-Mark certification in 2024 and the company expects to obtain FDA approval by the end of 2025. The company is currently conducting a multicentre prospective clinical study to gather data demonstrating the level of dose attenuation to provide further evidence that Nova-X® enables safe lead-free procedures.
Based in Nantes, France, Cathpax aims to become the world leader in full-body, team-wide radiation protection in interventional medicine in the coming years.